Evaluation of Eventual Risks of Unseeded Inertial Cavitation for Enhancing the Delivery of Chemotherapies - Centre de recherche en cancérologie de Lyon (UMR INSERM 1052 ; CNRS 5286 ; Centre Léon Bérard) Accéder directement au contenu
Communication Dans Un Congrès Année : 2015

Evaluation of Eventual Risks of Unseeded Inertial Cavitation for Enhancing the Delivery of Chemotherapies

Résumé

Acoustic cavitation is widely used to improve drug delivery in tumors. In this study, we evaluate the safety of using unseeded inertial cavitation (without external nucleation agents) for this application. We show that unseeded inertial cavitation (UIC) does not degrade doxorubicin molecules or alter its cytotoxicity. Moreover, histopathologic analysis shows only slight or reversible moderate effects on healthy tissues. Finally, UIC does not promote metastatic spreading. Thus, the particular conditions used in this study provide the possibility of safe UIC concerning these three points.
Fichier principal
Vignette du fichier
ACTES-RITS2015-HAL-p70-71.pdf (86.02 Ko) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)
Loading...

Dates et versions

inserm-01145626 , version 1 (24-04-2015)

Licence

Paternité

Identifiants

  • HAL Id : inserm-01145626 , version 1

Citer

Maxime Lafond, Jean-Louis Mestas, Fabrice Prieur, Kamel Chettab, Philippe Clézardin, et al.. Evaluation of Eventual Risks of Unseeded Inertial Cavitation for Enhancing the Delivery of Chemotherapies. Journées RITS 2015, Mar 2015, Dourdan, France. p70-71 Section imagerie et thérapie par ultrasons. ⟨inserm-01145626⟩
74 Consultations
64 Téléchargements

Partager

Gmail Facebook X LinkedIn More